Perbedaan DCI Indonesia Tbk dan Kalbe Farma Tbk: DCI Indonesia Tbk diperdagangkan di Rp198.675 (kapitalisasi pasar 473,71 T, volume 24 jam 1 rb), sedangkan Kalbe Farma Tbk diperdagangkan di Rp705 (kapitalisasi pasar 34,17 T, volume 24 jam 156,61 jt). Perbedaan utamanya: DCI Indonesia Tbk jauh lebih besar — sekitar 13,9× kapitalisasi pasar Kalbe Farma Tbk, dan Kalbe Farma Tbk lebih aktif diperdagangkan (156,61 jt vs 1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DCII | KLBF | |
|---|---|---|
Kapitalisasi Pasar | 473,71 T | 34,17 T |
Volume | 1 rb | 156,61 jt |
Lot | 10 | 1,57 jt |
Perputaran | 194,12 jt | 111,23 M |
Harga Rata-rata | 194.120 | 710,21 |
Nilai Transaksi | 194,12 jt | 111,23 M |
Harga Ekuilibrium Indikatif | 199.000 | 705 |
Volume Ekuilibrium Indikatif | 1 | 56,1 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Selengkapnya di halaman DCII →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →